Providing schools, colleges, and universities with a scalable COVID-19 testing solution to rapidly return students, faculty, and staff to campus and help maintain continuity in campus life.
Providing employers with a comprehensive, on-site COVID-19 testing solution for ongoing safety and business continuity.
OmeCare has validated an FDA EUA authorized COVID-19 real-time PCR test in our CLIA/CAP-accredited laboratory. All testing is performed by California-licensed laboratory scientists specially-trained in performing the COVID-19 testing. All processes are completed in a BSL-2 safety level laboratory and comply with the Centers for Disease Control and Prevention (CDC) guidelines on social distancing and enhanced cleaning procedures.
Employers and School Administrators,
start planning a return to the
workplace, school, or campus!
Let us partner with you to implement your organization’s testing strategy.
Please complete the following form below and
our team will follow up within one (1) business day.
Any Individual wishing to have COVID-19 testing should consult with their physician or authorized healthcare provider to order the test. Once an order is obtained, the patient should have his/her authorized healthcare provider collect the specimen and submit the specimen to OmeCare.
OmeCare performs a FDA-EUA approved real-time reverse transcription polymerase chain reaction (real-time RT-PCR) assay to detect the presence of SARS-CoV2.
Turnaround time for COVID-19 testing is generally 2-3 days from the receipt of the specimen at OmeCare laboratory. Most results can be ready within 48 hours but may vary depending on demand volumes and specimen quality issues.
Written test results are provided to the ordering physician or authorized healthcare provider. OmeCare may also deliver test results via our secure physician portal. All results will be reported to appropriate third parties as may be required by law (e.g., CDC, CMS, etc.).
OmeCare only accepts saliva samples collected with a FDA-EUA approved Saliva collection device following the manufacturer-approved IFU for the collection process. Once the sample is obtained, it should be mixed with the collection media provided in the collection device, per enclosed IFU.
The collected specimen must be stored and shipped at ambient temperature with proper packaging protection within no more than 14 days prior to testing. If a delay in testing or shipping is expected, freeze specimen at -70 °C or below and ship overnight on dry ice. Upon request, OmeCare will arrange for the specimen to be shipped to its facility.
OmeCare will report COVID-19 results to the appropriate public health agency in accordance with applicable legal requirements.
Please find technical information regarding the FDA-approved test kit used by OmeCare to perform COVID-19 testing at the following links: